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We report here five improved high-quality draft genomes of Burkholderia pseudomallei isolated from Australian cystic fibrosis
(CF) patients. This pathogen is rarely seen in CF patients. These genomes will be used to better understand chronic carriage of
B. pseudomallei in the CF lung and the within-host evolution of longitudinal isolates from these patients.
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Burkholderia pseudomallei is the causative agent of melioidosis,a potentially lethal disease with multiple clinical presenta-
tions, of which pneumonia is most common (1–3). Infection with
B. pseudomallei is acquired following accidental percutaneous in-
oculation with contaminated soil or water, or by inhalation or
ingestion. Most reported cases of melioidosis are from the regions
of northern Australia and Southeast Asia that are highly endemic
for B. pseudomallei, with sporadic reports from other endemic
regions, including the Middle East, Africa, South and Central
America, and the Caribbean (4, 5).
Cystic fibrosis (CF) patients typically develop infections caused
by a range of opportunistic pathogens, such as Pseudomonas
aeruginosa, Staphylococcus aureus, and Haemophilus influenzae,
which may be eradicated in the early phases, but with increasing
age, these can develop into a chronic infection (6). The factors that
promote the development of infection are complex but include
the abnormal composition of the airway lining fluid as a conse-
quence of abnormal expression of the CF transmembrane regula-
tor protein (CFTR). B. pseudomallei has been identified in the CF
lung in a small proportion of CF patients living or traveling to
regions endemic for the pathogen (7–12).
B. pseudomallei is known to cause chronic infections that can
be difficult to treat and, in certain instances, persist for years (13,
14). Although many conventional CF-associated pathogens have
been studied in detail, little is known about how B. pseudomallei
behaves within the CF lung. Reports have demonstrated that, like
most B. pseudomallei infections, clinical symptoms can present as
either acute or chronic disease (9). Here, we present improved
high-quality draft genome sequences (15) of the initial B. pseu-
domallei strains isolated from five Australian CF patients with
chronic B. pseudomallei infection.
DNA was extracted from purified culture, as previously re-
ported (16). The DNA samples were subjected to whole-genome
sequencing (WGS) from a paired-end Nextera library and with a
~300-bp insertion size using the Illumina HiSeq 2000 platform
(Illumina, Inc., San Diego, CA) at Macrogen, Inc. (Geumcheon-
gu, Seoul, Republic of Korea). The genomes of the isolates (ex-
cluding MSHR8441) were also sequenced using the 454 Genome
Sequencer FLX instrument (454 Life Sciences, Branford, CT,
USA). The sequence reads were quality-filtered and subsequently
assembled via hybrid assembly using MIRA (17), followed by
PAGIT (18), SSPACE version 2.0 (19), and GapFiller version 1.10
(20) polishing. MSHR8441 was assembled using Velvet version
1.2.10 (21) instead of MIRA but included the same quality im-
provement steps listed above. The contigs were reordered against
B. pseudomallei MSHR1153 (GenBank accession numbers
CP009271 and CP009272 [22]) or K96243 (GenBank accession
numbers NC_006350 and NC_006351 [23]) using Mauve (24).
The contig joins were manually checked for synteny among refer-
ence genomes using BLAST and were stitched, if possible. A sum-
mary of the final genome assembly statistics is provided in Table 1.
These genomes will provide useful reference strains for use in
TABLE 1 Statistics for the 5 Burkholderia pseudomallei draft genome sequences
Strain Alternate ID Accession no. Genome size (bp) No. of contigs N50 (bp) GC content (%)
QCMRI_BP07 MSHR5651 JYBG00000000 7,767,989 139 227,078 67.6
QCMRI_BP13 MSHR8436 JYBH00000000 7,356,204 98 241,256 68.0
QCMRI_BP18 MSHR5662 JYBI00000000 7,391,892 83 755,997 68.0
QCMRI_BP28 MSHR8438 JYBJ00000000 7,565,815 161 398,485 67.7
QCMRI_BP32 MSHR8441 JYBK00000000 7,108,439 39 371,315 68.2
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analyses of longitudinal isolates from the same patient and pro-
vide novel insights into the within-host evolution and adaptation
of B. pseudomallei in the CF lung. More broadly, these genomes
will be useful for identifying parallel evolutionary mechanisms
with other Gram-negative pathogens affecting the CF lung.
Nucleotide sequence accession numbers. The genome acces-
sion numbers for the assemblies deposited in DDBJ/ENA/Gen-
Bank are listed in Table 1.
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